Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Kanghua Healthcare to Raise $154 Million in Hong Kong IPO

publication date: Oct 27, 2016
Guangdong Kanghua Healthcare is on track to complete a $154 million IPO in Hong Kong in early November. The company owns two private hospitals in Dongguan, a city in China's southern Guangdong province, with a total of 2,486 registered beds. Currently, a regional hospital operator, Kanghua must expand geographically to grow. It will devote 35% of the IPO's proceeds to buying other China hospitals. Ultimately, it plans to own 30 hospitals with 15,000 beds, according to the company's chairman, Junyang Wang. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital